fig1 - 4 illustrate pharmaceutical tablet 20 having bevel edge 22 disposed about the bottom peripheral edge thereof with bevel edge 24 disposed about the top peripheral edge . these bevel edges may vary as desired and typically range from about 25 ° to about 50 ° from the horizontal plane . one side of pharmaceutical tablet 20 is defined by vertical wall 26 , intermediately disposed vertical score 28 and second vertical wall 30 . similarly , the opposite side of pharmaceutical tablet 20 is essentially the same configuration except defined by vertical wall 32 , intermediately disposed vertical score 34 , and second vertical wall 36 . the end sections of tablet 20 are defined by vertical walls 44 and 46 respectively . the top and bottom surfaces of pharmaceutical tablet 20 also approximately duplicate each other with the top surface defined by horizontal planar surface 38 , intermediate horizontal planar surface 40 and second horizontal planar surface 42 . the horizontal planar surface 38 is joined to the intermediate horizontal planar surface 40 by transversely disposed top score 48 whereas intermediate horizontal planar surface 40 is joined to the second horizontal planar surface 42 by transversely disposed second top score 50 . similarly , the bottom surface of pharmaceutical tablet 20 is defined by bottom horizontal planar surface 52 which joins transversely disposed bottom score 54 and bottom intermediate horizontal planar surface 56 . this latter surface joins together a second transversely disposed bottom score 58 and second horizontal planar surface 60 . for consumption purposes , pharmaceutical tablet 20 may be administered as a unitary dosage . in the event a half dosage is desired , the tablet may be fractured conveniently along score markings 28 - 34 , while one - third dosages may be administered by fracturing the tablet respectively along score markings 48 - 54 and 50 - 58 . it will also be appreciated that a one - third dosage may be administered by fracturing the tablet along , for example , score markings 48 - 54 , with the remaining two - third dosage unit being separately consumed . fig5 - 8 illustrates an embodiment pharmaceutical tablet 62 of the present invention having bevel edge 64 , similar to that of tablet 20 , disposed about the bottom peripheral edge , with bevel edge 66 correspondingly positioned about the top peripheral edge . one side of pharmaceutical tablet 62 is defined by vertical wall 68 , intermediately disposed vertical score 70 and second vertical wall 72 . similarly , the opposite side of pharmaceutical tablet 62 is essentially the same configuration except defined by vertical wall 70 , intermediately disposed vertical score 72 , and second vertical wall 74 . the essential distinction of the tablet structure 62 over the tablet structure 20 resides in the significant depth of the score markings 70 - 72 . these score markings may be impressed to depths beyond the bevel edge as opposed to the score markings 28 - 34 which essentially project to the horizontal planar surface of the top and bottom portions of tablet 20 . score markings 70 - 72 may be at a v - groove angle of about 40 ° to 50 °, and preferably about 45 °, with each v - groove depth being about 1 / 4 to about 1 / 3 the width of the tablet . the top and bottom surfaces of pharmaceutical table 62 also approximately duplicate each other , with the top surface defined by horizontal planar surface 76 , intermediate horizontal planar surface 78 and second horizontal planar surface 80 . the horizontal planar surface 76 is joined to the intermediate horizontal planar surface 78 by transversely disposed top score 82 , again similar to the corresponding score marking 48 of tablet 20 , whereas intermediate horizontal planar surface 78 is joined to the second horizontal planar surface 80 by transversely disposed second top score 84 . similarly , the bottom surface of pharmaceutical tablet 62 is defined by bottom horizontal planar surface 90 which join transversely disposed bottom score 92 and bottom intermediate horizontal planar surface 94 . this latter surface joins together a second transversely disposed bottom score 96 and second horizontal planar surface 98 . the end walls of tablet 62 are defined by vertical walls 86 and 88 respectively . again , for consumption purposes , pharmaceutical tablet 62 may be administered as a unitary dosage . in the event a half dosage is desired , the tablet may be fractured conveniently along score markings 70 - 72 , while one - third dosages may be administered by fracturing the tablet respectively along score markings 82 - 92 and 84 - 96 . it will also be appreciated that a one - third dosage may be administered by fracturing the tablet along , for example , score markings 82 - 92 , with the remaining two - thirds dosage unit being separately consumed . fig9 - 12 illustrate an embodiment pharmaceutical tablet 100 of the present invention having bevel edge 102 disposed about only the top peripheral edge . one side of pharmaceutical tablet 100 is defined by arcuate vertical wall 104 , intermediately disposed vertical score 106 and second arcuate vertical wall 108 . similarly , the opposite side of pharmaceutical tablet 100 is essentially the same configuration except defined by arcuate vertical wall 124 , intermediately disposed vertical score 126 , and second arcuate vertical wall 128 . the end portions of tablet 100 appear as substantially vertical wall surfaces 120 and 122 respectively . the vertical score markings 106 and 126 of tablet 100 are configurated similar to score markings 70 and 72 of tablet 62 . correspondingly , the size and angle dimensions are similar for practical purposes of construction . the top and bottom surfaces of pharmaceutical tablet 100 present a significant contrast in that the top surface is defined by horizontal planar surface 110 , intermediate horizontal planar surface 112 and a second horizontal planar surface 114 . the horizontal planar surface 110 is joined to the intermediate horizontal planar surface 112 by transversely disposed top score 118 , whereas intermediate horizontal planar surface 112 is joined to the second horizontal planar surface 114 by transversely disposed second top score 116 . score markings 116 and 118 are deeply grooved indentations having a v - groove angle of about 55 ° to about 65 °, with an angle of about 60 ° being preferred . the depth of these v - grooves may vary from about 1 / 4 to about 5 / 8 of the thickness of the tablet . the bottom surface of pharmaceutical tablet 100 is defined by a slightly arcuate surface 130 which joins transversely disposed bottom score 132 and bottom intermediate surface 134 . this latter surface joins together a second transversely disposed bottom score 136 and second slightly arcuate surface 138 . the v - groove score markings 132 and 136 vary from an angle of about 55 ° to about 65 ° with about 60 ° being preferred . however , and significantly , score markings 132 and 136 only slightly indent into the bottom surface of tablet 100 . typically , this depth varies from about 1 / 8 to about 1 / 4 of the thickness of this tablet . for consumption purposes , pharmaceutical tablet 100 may be also administered as a unitary dosage . in the event a half dosage is desired , the tablet may be fractured conveniently along score markings 106 - 126 , while one - third dosages may be administered by fracturing the tablet respectively along score markings 118 - 132 and 116 - 136 . it will also be appreciated that a one - third dosage may be administered by fracturing the tablet along , for example , score markings 118 - 132 , with the remaining two - third dosage unit being separately consumed . fig1 - 15 illustrate yet another embodiment pharmaceutical tablet 140 which approximates the configuration of tablet 62 except the correspondingly defined top and side score markings are shifted 90 degrees to the side and bottom surfaces respectively . the remaining bottom and opposite side score markings are also transposed that same extent . pharmaceutical tablet 140 includes bevel edge 142 disposed about the top peripheral edge thereof , also similar in configuration to the bevel edge 24 of tablet 20 . the top and bottom surfaces of pharmaceutical tablet 140 have correspondingly configurated surfaces in that the top surface is defined by horizontal planar surface 144 , and a second horizontal planar surface 148 . the horizontal planar surface 144 is joined to the second horizontal planar surface by transversely disposed top score 146 . the front and rear surfaces of pharmaceutical tablet 140 also approximately duplicate each other with the front surface defined by vertical surface 154 , intermediate vertical surface 160 and second vertical surface 164 . the vertical surface 154 is joined to the intermediate vertical surface 160 by score marking 158 , whereas intermediate vertical surface 160 is joined to the second vertical surface 164 by second score marking 162 . similarly , the opposite side surface of pharmaceutical tablet 140 is defined by vertical surface 166 which joins first score marking 168 , and intermediate vertical surface 170 . this latter surface joins together a second score marking 172 and second vertical surface 174 . the corner edges of tablet 140 may also be tapered as desired such as elements 156 illustrating a taper of approximately 45 degrees . score markings 158 , 162 , 168 and 172 are all correspondingly configurated with v - grooves having an approximate v - angle of about 40 to about 50 degrees , with an angle of about 45 degrees being preferred , with each v - groove depth being about 1 / 4 to about 1 / 3 the thickness of the tablet . score markings 146 and 178 may be configurated similarly to the related score markings 82 of the tablet 62 . the dosages which may be extracted using tablet 140 approximately correspond to that of tablet 62 except , however , accounting for the 90 degree transposition of surfaces . fig1 - 18 illustrate pharmaceutical tablet 186 having bevel edge 188 disposed about the upper peripheral edge thereof with bevel edge 205 disposed about the bottom peripheral edge . these bevel edges may vary as desired and typically range from about 25 ° to about 50 ° from the horizontal plane . one side of pharmaceutical tablet 186 is defined by vertical wall 200 whereas the opposite side is defined by vertical wall 204 . in similar regard , the front surface of tablet 186 is defined by vertical wall 206 whereas the oppositely disposed rear portion is defined by vertical wall 208 . the top surface of pharmaceutical tablet 186 is uniquely distinct from the bottom thereof . the top surface is defined by horizontal planar surface 190 , intermediate horizontal planar surface 192 and second horizontal planar surface 194 . planar surface 190 is joined to the intermediate horizontal planar surface 192 by means of score marking 196 , whereas the intermediate planar surface 192 is joined to the second horizontal planar surface 194 by means of second score marking 198 . the bottom surface of pharmaceutical tablet 186 is defined by a first bottom planar surface 210 , joined by a longitudinally disposed score marking 216 to a second bottom planar surface 214 . score markings 196 , 198 and 216 may have similar v - groove configurations and for constructions purposes , are similarly configurated to score markings 48 and 50 of tablet 20 . for consumption purposes , pharmaceutical tablet 186 may be administered as a unitary dosage . in the event a half dosage is desired , the tablet may be fractured conveniently along score marking 216 , while one - third dosages may be administered by fracturing the tablet respectively along score markings 196 and 198 . it will also be appreciated that further sub - dosage units may be administered by fracturing the tablet along , for example , score markings 196 , 198 as well as 216 . the present multi - fractionable tablet structure includes specially positioned score markings for either at least an accurate bisectional fracture of the tablet or accurate trifunctional fracture . it will be apparent that with the same convenience , positioning of the score markings may permit fracture of pharmaceutical tablet 186 into as many as six substantially equivalent dosages . correspondingly , the remaining pharmaceutical tablets , namely , 20 , 62 , 100 and 140 may be fractured readily into two pairs of equivalent dosages with , for example , fracture along score markings 48 - 54 and score markings 50 - 58 of pharmaceutical tablet 20 defining one pair of dosage units with further fracture along score markings 28 - 34 defining the second pair of dosage units . tablets of the present invention may be composed of a variety of ingredients such as one or more active pharmaceutical ingredients , fillers , lubricants , carriers , flavoring ingredients or the like as desired . these materials are well known to skilled tablet formulators . although it has not been specially disclosed herein , it will be appreciated that the present multi - fractionable tablet structure may be specially marked with a corporate logo or otherwise colored as desired to reflect particular dosage units being consumed . also , the present tablet may be coated with suitable materials well known in the tablet formation art . having described the present invention with particular reference to the disclosed embodiments , it will be obvious to those skilled in this art , that various changes and modifications may be made therein without departing from the spirit and scope of the invention which is disclosed and claimed herein .
the invention disclosed provides a multi - fractionable tablet structure initially configurated in a unitary dosage while having readily severable sub - dosage units as components thereof . score markings are positioned variously about the tablet both along the top and bottom surfaces of an approximately rectangular configuration whereas in preferred embodiments thereof , score markings additionally appear along opposite vertical side surfaces of the tablet . special placement of the score markings readily permit at least either an accurate bisectional fracture or accurate trisectional fracture of the tablet as may be desired for patient consumption .